Sfoglia per AUTORE
VAN DE VELDE H
Collezione AOU Città della Salute di Torino

  

Items : 6

Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies. in Blood cancer journal / Blood Cancer J. 2024 Nov 28;14(1):209. doi: 10.1038/s41408-024-01149-w.
2024
AOU Città della Salute di Torino

Richardson PG; Perrot A; Mikhael J; Martin T; Beksac M; Spicka I; Capra M; D'Agostino M; Sonneveld P; Bisht K; Fukao T; Zhang R; Tada K; Tekle C; Macé S; Klippel Z; van de Velde H; Moreau P;

Evaluation of isatuximab in patients with soft-tissue plasmacytomas: An analysis from ICARIA-MM and IKEMA. in Leukemia research / Leuk Res. 2022 Nov;122:106948. doi: 10.1016/j.leukres.2022.106948. Epub 2022 Sep 6.
2022
AOU Città della Salute di Torino

Rawlings AM; Moreau P; Symeonidis A; Martin T; Mikala G; Jelínek T; Bringhen S; Hajek R; Spicka I; Beksac M; van de Velde H; Richardson PG;

Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis. in Haematologica / Haematologica. 2022 Mar 1;107(3):774-775. doi: 10.3324/haematol.2021.279160.
2022
AOU Città della Salute di Torino

Schjesvold F; Richardson PG; Facon T; Alegre A; Spencer A; Jurczyszyn A; Sunami K; Frenzel L; Min CK; Guillonneau S; Lin PL; Le-Guennec S; Campana F; Van de Velde H; Bensfia S; Bringhen S;

Isatuximab plus pomalidomide and dexamethasone in frail patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis. in American journal of hematology / Am J Hematol. 2021 Nov 1;96(11):E423-E427. doi: 10.1002/ajh.26319. Epub 2021 Sep 23.
2021
AOU Città della Salute di Torino

Schjesvold F; Bringhen S; G Richardson P; Perrot A; Leleu X; Moreau P; A Dimopoulos M; Hulin C; Tekle C; Foster MC; Poole EM; van de Velde H; Facon T;

2021
AOU Città della Salute di Torino

Bringhen S; Pour L; Vorobyev V; Vural F; Warzocha K; Benboubker L; Koh Y; Maisnar V; Karlin L; Pavic M; Campana F; Le Guennec S; Menas F; van de Velde H; Richardson PG;

Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis. in Haematologica / Haematologica. 2021 Apr 1;106(4):1182-1187. doi: 10.3324/haematol.2020.253450.
2021
AOU Città della Salute di Torino

Schjesvold FH; Richardson PG; Facon T; Alegre A; Spencer A; Jurczyszyn A; Sunami K; Frenzel L; Min CK; Guillonneau S; Lin PL; Le-Guennec S; Campana F; van de Velde H; Bensfia S; Bringhen S;